tag:blogger.com,1999:blog-42881234888787155242024-03-05T23:15:22.868-08:00The right to treatment and research of cannabis European Commission, BrusselsUnknownnoreply@blogger.comBlogger5125tag:blogger.com,1999:blog-4288123488878715524.post-41303683805849069382017-11-29T08:44:00.002-08:002017-11-29T08:45:18.212-08:00Vláda České republiky uvádí v níže uvedeném rozhodnutí dne 28.11.2017 č.j. 30804/2017-OPR-4 právo Evropanů obchodovat konopí k terapii a výzkumu a uvádí evropskou a českou vládní politiku a národní strategie k harm reduction u cannabis <div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<span style="font-family: "courier new" , "courier" , monospace;">➤ <a href="http://eu-commission.blogspot.cz/2016/01/priloha-c-1-narizeni-es-c-11222009.html"><b>Metodu</b> <b>Společenství</b> k určení stopy (60/200 ks), období sběru (30 dní od nakvetení) a vzorku konopí (vrcholík) na <b>určení obsahu kanabinoidu THC</b> v konopí najdeme v <b>Příloze č. 1 Nařízení ES č. 1122/2009</b> </a><span style="text-align: left;">➤</span></span></div>
<div style="text-align: justify;">
<span style="font-family: "courier new" , "courier" , monospace;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><span style="font-family: "courier new" , "courier" , monospace;">➤ <b><a href="http://predseda-vlady.blogspot.cz/2017/11/prezident-predseda-vady-ceske-republiky.html">Rozhodnutí prezidentů a premiérů Vlády ČR</a></b> ode dne 21.3.2008 a zveřejnění výzkumu a podání prvního legislativního návrhu zajištění konopí k léčbě a výzkumu (<a href="http://www.konopijelek.cz/"><b>www.konopijelek.cz</b></a>) do dne 17.11.2017 vůči </span></span><span style="font-family: "courier new" , "courier" , monospace; text-align: left;">členům výzkumu Konopí je lék (Cannabis is The Cure)a stížnostem </span><span style="text-align: left;"><span style="font-family: "courier new" , "courier" , monospace;"><a href="http://predseda-vlady.blogspot.cz/2017/11/prezident-predseda-vady-ceske-republiky.html" style="font-weight: bold;">na porušování čl. 2 a 3 Evropské úmluvy o lidských právech a čl. 34 a 267 Smlouvy o fungování Společenství </a>Českou republikou </span></span><span style="font-family: "courier new" , "courier" , monospace; text-align: left;">➤</span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><span style="font-family: "courier new" , "courier" , monospace;"><br /></span></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><span style="font-family: "courier new" , "courier" , monospace;">Úřad vlády ČR dne 28.11.2017 č.j. 30804/2017-OPR-4</span></span></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtxJGTBnkAvbDE345G0CpY693J5udc_V9GtIO6v6EMnCDQHghD-5Alu-HQWpQ7e3gARGlocF5U5_V55neiyzA5OVtvW99ePWVMqbEHNnxYpmWWVlWLV487RCv6nYbjf26m6c20GsepItla/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtxJGTBnkAvbDE345G0CpY693J5udc_V9GtIO6v6EMnCDQHghD-5Alu-HQWpQ7e3gARGlocF5U5_V55neiyzA5OVtvW99ePWVMqbEHNnxYpmWWVlWLV487RCv6nYbjf26m6c20GsepItla/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction.jpg" /></a></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEisXctJjin7-a4jtYDIzQ7nG6S4wc9pnKQpkVjuITcvEwMKizCZzyOoJhFUAHe6BpIePSgRwgUucJBFrz7cmiivlHjqC2D72n70cDxnKQ49sxPlPKKrBnU6DyB9uXnlGobTLGjAo9Wna93z/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEisXctJjin7-a4jtYDIzQ7nG6S4wc9pnKQpkVjuITcvEwMKizCZzyOoJhFUAHe6BpIePSgRwgUucJBFrz7cmiivlHjqC2D72n70cDxnKQ49sxPlPKKrBnU6DyB9uXnlGobTLGjAo9Wna93z/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B.jpg" /></a></div>
➤<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbn-wsy0pNNxDyv3_7eeVY3x8gwFFnMT9sbrYGN3-uLaomo2N_kkp0BrN4mj90QoftWJwCSQ__DpKtT98bV86ynUfSDmPvtRTV5rgVkvE9LITkjm0kf6JEn6835tjCUw7XWOimXtNDBvY_/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbn-wsy0pNNxDyv3_7eeVY3x8gwFFnMT9sbrYGN3-uLaomo2N_kkp0BrN4mj90QoftWJwCSQ__DpKtT98bV86ynUfSDmPvtRTV5rgVkvE9LITkjm0kf6JEn6835tjCUw7XWOimXtNDBvY_/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B.jpg" /></a></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;">➤</span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUMRsjv6DkX8c6VaqknJAct2A7aoe_-4pBuFwOdnbjysCaa9V8mgDotIyF7S69v5YVMKxE2vNy6ADj281NiB5T718q9J8X2SRrAfLSMWEI6LZWfEeg0HCu4FMGhJh0v-VxM0kMyRf4zBiL/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUMRsjv6DkX8c6VaqknJAct2A7aoe_-4pBuFwOdnbjysCaa9V8mgDotIyF7S69v5YVMKxE2vNy6ADj281NiB5T718q9J8X2SRrAfLSMWEI6LZWfEeg0HCu4FMGhJh0v-VxM0kMyRf4zBiL/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B.jpg" /></a></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;">➤</span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiq4qeimLnSipJ0C_E3UCWNSIQwE5Bx8ER5iGomcqEB_K9HS1Ocb45Ttytgvc0Dj5q_iL7dtCuUodOrDhxpsaZmfGIoKP0X0ujraDl1XZhjDpsFyiZtMTjswvrGlze2JlVmH9JTaR7PJ_cv/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B%252B.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiq4qeimLnSipJ0C_E3UCWNSIQwE5Bx8ER5iGomcqEB_K9HS1Ocb45Ttytgvc0Dj5q_iL7dtCuUodOrDhxpsaZmfGIoKP0X0ujraDl1XZhjDpsFyiZtMTjswvrGlze2JlVmH9JTaR7PJ_cv/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B%252B.jpg" /></a></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;">➤➤</span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiubC7AKd7a4Dgg8e1dewH-wwrWGEL8oQp_j4JBbqyniHZb3RDkELxYksbPVm84uZwEI_nPDsVwZwF0p4wuuD0gsBnTNU4rUaAW86vEO43rCac-OXY8_dGHbi3JFicRUJaxnxqFPmIWH2fj/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B%252B%252B.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiubC7AKd7a4Dgg8e1dewH-wwrWGEL8oQp_j4JBbqyniHZb3RDkELxYksbPVm84uZwEI_nPDsVwZwF0p4wuuD0gsBnTNU4rUaAW86vEO43rCac-OXY8_dGHbi3JFicRUJaxnxqFPmIWH2fj/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B%252B%252B.jpg" /></a></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;">➤</span></div>
<div style="text-align: justify;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjOq-I9ZbxHiM2BDuCpfWZG9UyL5BTpH1wzraO3lsgZT1W5ml13ycvFGZ87D0HMHQNF2Nv-wOMeMzfk5AzJj3DGWwuZHpu_lo4v3Za_PrITcnqb5lPxM2cYQCak_00L0yb5R2lbz-rSQo3D/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B%252B%252B%252B%252B.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1132" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjOq-I9ZbxHiM2BDuCpfWZG9UyL5BTpH1wzraO3lsgZT1W5ml13ycvFGZ87D0HMHQNF2Nv-wOMeMzfk5AzJj3DGWwuZHpu_lo4v3Za_PrITcnqb5lPxM2cYQCak_00L0yb5R2lbz-rSQo3D/s1600/%25C3%259A%25C5%2599ad+vl%25C3%25A1dy+%25C4%258CR+ze+dne+28.11.2017+%25C4%258Cj.+30804-2017-OPR-4+k+harm+reduction%252B%252B%252B%252B%252B%252B%252B.jpg" /></a></div>
<span style="text-align: left;"><br /></span></div>
<div style="text-align: justify;">
<span style="text-align: left;">➤➤</span></div>
, </div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-4288123488878715524.post-46331708770234354502016-01-08T09:48:00.000-08:002017-01-06T10:56:34.023-08:00Příloha č. 1 Nařízení ES č. 1122/2009<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: 10.0pt;"></span></div>
<div class="Default">
<span style="color: red;"><span style="font-size: x-large;"><b><span style="font-family: "bookman old style" , "serif";">Metoda
společenství pro kvantitativní určení obsahu delta-9-tetrahydrokannabinolu v
odrůdách konopí</span></b><span style="font-family: "bookman old style" , "serif";">. </span></span></span></div>
<div class="Default">
<br /></div>
<div class="Default">
<br /></div>
<div class="Default">
<span style="font-size: large;"><b><span style="font-family: "bookman old style" , "serif";">Rozsah
a oblast použití</span></b></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Tato
metoda slouží k určení obsahu delta-9-tetrahydrokannabinolu (dále jen „THC“) v
odrůdách konopí (<i>Cannabis sativa L</i>.). </span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Podle potřeby je uplatňována podle
postupu A nebo B, které jsou zde popsány.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Metoda
je založena na kvantitativním určení delta-9-THC pomocí plynové chromatografie
(GC) po extrakci vhodným rozpouštědlem.1.1. </span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><i><span style="font-family: "bookman old style" , "serif";">Postup
A</span></i></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><a href="http://eur-lex.europa.eu/legal-content/CS/ALL/?uri=CELEX:32009R0073"><span style="font-family: "bookman old style" , "serif";">Postup Ase používá pro kontroly produkce podle článku 39 nařízení (ES) č. 73/2009 a čl.30 odst. 2 písm. a) tohoto nařízení.1.2. </span></a></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><i><span style="font-family: "bookman old style" , "serif";">Postup
B</span></i></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><a href="http://eur-lex.europa.eu/legal-content/CS/ALL/?uri=CELEX:32009R0073"><span style="font-family: "bookman old style" , "serif";">Postup B
se používá v případech, které jsou uvedeny v čl. 39 odst. 1 nařízení (ES) č.
73/2009 a v čl. 40 odst. 3 tohoto nařízení 2. </span></a></span></div>
<span style="font-size: large;"><a href="http://eur-lex.europa.eu/legal-content/CS/ALL/?uri=CELEX:32009R0073">
</a></span><br />
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><b><span style="font-family: "bookman old style" , "serif";">Odběr
vzorků</span></b></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">2.1. <i>Vzorky</i></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default" style="margin-bottom: 12.05pt; text-align: justify;">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Postup
A: z porostu dané odrůdy konopí se odebere <b>z každé vybrané rostliny část <span style="color: red;">dlouhá
30 cm, která obsahuje</span> <span style="color: red;">nejméně jedno samičí květenství.</span></b> Odběr vzorků se provádí
v období, které začíná <u><b><span style="color: red;">20. den po rozkvětu a končí 10. den po odkvětu</span>,</b></u> během
dne a při dodržení systematického postupu, který zajišťuje reprezentativnost
vzorků pro dané pole, <span style="color: red;"><u><b>avšak s výjimkou okrajů porostu.</b></u></span></span></div>
<div class="Default" style="text-align: justify;">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Členské
státy mohou povolit odběr vzorků v období od rozkvětu do 20. dne po rozkvětu za
předpokladu, že u každé pěstované odrůdy se odeberou další reprezentativní
vzorky v souladu s prvním pododstavcem v období <span style="color: red;"><b><u>od 20. dne po rozkvětu do 10.
dne po odkvětu.</u></b></span></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default" style="text-align: justify;">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Postup
B: z porostu dané odrůdy konopí se odebere <span style="color: red;"><b>horní třetina každé vybrané
rostliny</b></span>. Odběr vzorků se provádí v průběhu <span style="color: red;"><b>10 dnů po odkvětu</b></span>, během dne a při
dodržení systematického postupu, který zajišťuje reprezentativnost vzorků pro
dané pole, avšak s výjimkou okrajů porostu. <span style="color: red;"><u><b>V případě dvoudomých odrůd se
odebírají pouze samičí rostliny.</b></u></span></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">2.2. <i>Velikost
vzorku</i></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Postup
A: vzorek je tvořen částmi <b><span style="color: red;">50</span> </b>rostlin na jedno pole.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Postup
B: vzorek je tvořen částmi 200 rostlin na jedno pole.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Každý
vzorek se umístí do plátěného nebo papírového pytle tak, aby se nerozdrtil, a
zašle se do laboratoře k analýze.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Členské
státy mohou stanovit, že se odebírá druhý vzorek pro případnou kontrolní
analýzu, který uschová buď producent, nebo subjekt odpovědný za analýzu.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">2.3. <i>Sušení
a skladování vzorků</i></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Sušení
vzorků musí začít co nejdříve, v každém případě do 48 hodin a používá se
jakákoli metoda s teplotou nižší než 70 °C.</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Vzorky
se usuší tak, aby měly stálou hmotnost a <span style="color: red;"><b>obsah vody mezi 8 % a 13 %. </b></span></span><br />
<span style="font-family: "bookman old style" , "serif"; font-size: large;">SC9
002.21.2</span><br />
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Úřední věstník Evropské unie 2. 12. 2009 </span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Po
vysušení se <b>vzorky <span style="color: red;">bez rozdrcení</span> uskladní v temnu při teplotě do 25 °</b></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">C.3. </span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><b><span style="font-family: "bookman old style" , "serif";">Stanovení
obsahu THC</span></b></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">3.1. <i>Příprava
zkušebního vzorku</i></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Z
vysušených vzorků se odstraní stonky a semena větší <span style="color: red;"><b>než 2 mm.</b></span></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Vysušené
vzorky se rozdrtí na středně jemný prášek </span><br />
<span style="font-family: "bookman old style" , "serif"; font-size: large;">(skrze síto s oky o velikosti 1 mm).</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Prášek
lze skladovat 10 týdnů v temnu a suchu při teplotě do 25 °C.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">3.2. <i> </i></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;"><i>Činidla a
extrakční roztok</i></span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Činidla</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">—</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">delta-9-tetrahydrokannabinol,
čistý pro chromatografické účely, —</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">skvalen,
čistý pro chromatografické účely, jako vnitřní standardní vzorek.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Extrakční
roztok</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">—</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">35 mg
skvalenu na 100 ml hexanu.3.3. </span><br />
<span style="font-size: large;"><br /></span>
<span style="font-family: "bookman old style" , "serif"; font-size: large;"><i>Extrakce delta-9-THC</i></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Odváží
se 100 mg zkušebního vzorku rozmělněného na prášek, umístí se do odstředivkové
zkumavky a přidá se 5 ml extrakčního roztoku obsahujícího vnitřní standardní
vzorek.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Vzorek
se umístí do ultrazvukové lázně a ponechá se zde 20 minut. </span><br />
<span style="font-size: large;"><br /></span>
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Pět minut se
odstřeďuje při 3 000 otáčkách za minutu a pak se odebere roztok THC plovoucí na
povrchu. </span><br />
<span style="font-size: large;"><br /></span>
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Tento roztok se vstříkne do chromatografu a provede se kvantitativní
analýza.</span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">3.4. </span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-size: large;"><i><span style="font-family: "bookman old style" , "serif";">Plynová
chromatografie</span></i></span></div>
<div class="Default" style="margin-bottom: 10.65pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; mso-list: l0 level1 lfo1; text-indent: 0cm;">
<span style="font-family: "bookman old style" , "serif"; font-size: large; mso-bidi-font-family: "Bookman Old Style"; mso-fareast-font-family: "Bookman Old Style";"><span style="mso-list: Ignore;"><span style="font-family: "times new roman"; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;">
</span></span></span><span style="font-family: "bookman old style" , "serif"; font-size: large;"> </span></div>
<div class="Default" style="margin-bottom: 10.65pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; mso-list: l0 level1 lfo1; text-indent: 0cm;">
<span style="font-family: "bookman old style" , "serif"; font-size: large; mso-bidi-font-family: "Bookman Old Style"; mso-fareast-font-family: "Bookman Old Style";"><span style="mso-list: Ignore;"><span style="font-family: "times new roman"; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;">
</span></span></span><span style="font-family: "bookman old style" , "serif"; font-size: large;">Přístroje</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">—</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">plynový
chromatograf s plamenovým ionizačním detektorem a děleným/neděleným
vstřikovačem, —</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">kolona
umožňující dobré oddělení kanabinoidů, například skleněná kapilární kolona
dlouhá 25 m, o průměru 0,22 mm,</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">potažená
5 % nepolární fenylmethylsiloxanovou fází.</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Rozsahy
kalibrace</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Přinejmenším
tři body pro postup A a pět bodů pro postup B, včetně bodů 0,04 a 0,50
mg/ml-delta-9-THC v extrakčním roztoku.</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Pokusné
podmínky</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Jako
příklad pro kolonu uvedenou v bodu a) se uvádějí tyto podmínky:</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">—</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">teplota
v peci 260 °C, —</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">teplota
vstřikovače 300 °C, —</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">teplota
detektoru 300 °C.</span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Vstříknutý
objem: 1 μl </span></div>
<div class="Default">
<span style="font-size: large;"><br /></span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">SC6
01/613L 2.12.2009 CS </span></div>
<div class="Default">
<span style="font-family: "bookman old style" , "serif"; font-size: large;">Úřední věstník Evropské unie L 316/107 </span><br />
<br />
</div>
</div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-4288123488878715524.post-8169347954308896342015-11-30T05:00:00.001-08:002015-11-30T05:01:02.610-08:00European Commision<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijEUjNK2SlJhzNsVZ-1Gbz7vt_NvMaAXZZsuy3SqQOinlvyy6TYkYXC5qrVhrSv-tjPw7DR6HCXJ1uwnj_O9N4uGN5T-WwyHDle5HiTsyrPYLA-PgXJZ1CEfxx2hGRo3t8OQbuWZD1XIiQ/s1600/eK.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijEUjNK2SlJhzNsVZ-1Gbz7vt_NvMaAXZZsuy3SqQOinlvyy6TYkYXC5qrVhrSv-tjPw7DR6HCXJ1uwnj_O9N4uGN5T-WwyHDle5HiTsyrPYLA-PgXJZ1CEfxx2hGRo3t8OQbuWZD1XIiQ/s1600/eK.png" /></a></div>
<br /></div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-4288123488878715524.post-72110271328627139252015-11-30T04:59:00.002-08:002015-11-30T04:59:39.596-08:00Article 39 du Réglement de la Cour <div dir="ltr" style="text-align: left;" trbidi="on">
<!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
</xml><![endif]--><br />
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:HyphenationZone>21</w:HyphenationZone>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>CS</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:EnableOpenTypeKerning/>
<w:DontFlipMirrorIndents/>
<w:OverrideTableStyleHps/>
<w:UseFELayout/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Normální tabulka";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-para-margin-top:0cm;
mso-para-margin-right:0cm;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0cm;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]--><br />
<div align="center" style="text-align: center;">
<span style="font-size: 27.0pt;"></span></div>
<div align="center" style="text-align: center;">
<strong><span style="font-size: 27.0pt;">-
URGENT -</span></strong><br />
</div>
<div align="center" style="text-align: center;">
<span style="font-size: 27.0pt;">European
Court of Human Rights<br />
F-67075 Strasbourg, France</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">C</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">ontact:</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Répr<span style="color: red;">é</span>sent<span style="color: red;">ant</span> du requérant lors du <span style="color: red;">procès
</span>: QUIP-Společnost pro změnu, Karlínské nám. 12/59, Praha 8 - Karlín, 186
00, tel.: +420 221 890 434, email: dana.korinkova@kvalitavpraxi.cz</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Requérant:</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Dušan Dvořák, nar. 12. 1. 1962, bytem Tylova 2, 779 00
Olomouc, Česká republika</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">État contractant:</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">République tchèqu</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Organ<span style="color: red;">isme</span> <span style="color: red;">désigné pour prendre mesure du conflit</span>:</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Okresní soud v Olomouci (tribunal d'Olomouc), tř.
Svobody 16, 771 38 Olomouc, République tchèque,fax: +420 585 225 250, email:
posta@osoud.olc.justice.cz, tel: +420 585 503 111</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">I.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"><span style="mso-spacerun: yes;"> </span>Obj<span style="color: red;">et</span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Le requérant demande à la Cour Européenne des droits
de l'homme (ci après dénommée «la Cour») de bien vouloir ordonner des mesures
provisoires d'abstention dirigées contre la mesure de privation de capacité
juridique (civique) du requérant par le Tribunal d'Olomouc devant être prononcé<span style="color: red;">e</span> à l'audience du 10. Janvier 2013 – cf. l'ord<span style="color: red;">o</span>nnance de l'audience du tribunal d'Olomouc (voir
annexe 1).</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">La procédure d'urgence est bien fond<span style="color: red;">ée</span> parce que la privation de capacité juridique du
requérant constitu<span style="color: red;">e</span>rait une violation
injustifiée et grave de l'Art. 8 de la Convention dont l<span style="color: red;">e</span> seul b<span style="color: red;">u</span>t est de rendre impossible
l'exercice du droit du requérant garantit par l' Art. 6 phrase première de la
Convention et de museler les activit<span style="color: red;">és</span>
(juridiques) du requérant à promouvoir l'usage (réglementé) du chanvre <span style="color: red;">à</span> des fins médica<span style="color: red;">les</span>
comme sujet de société.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">L'audience susmentionnée fut ordonné<span style="color: red;">e</span> malgré la pro<span style="color: red;">testation</span>
de l'expert psychiatrique ordonné par les tribunaux protestant que les
tribunaux ont fait usage abusi<span style="color: red;">f</span> de son expertise
(voir annexe 2 – protestation<span style="mso-spacerun: yes;"> </span>de
l'expert psychiatrique) et malgré des prostestations de nombreux médecins (voir
annexe 3 – récapitulation des prostestations)<span style="color: red;">.</span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">II.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"><span style="mso-spacerun: yes;"> </span>Faits et
qualification juridique</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"><span style="mso-spacerun: yes;"> </span>Le requérant
fait actuellement encore face à trois accusations devant le Tribunal de
Prostějov pour cultivation entre 2010 à 2012 du chanvre ayant fourn<span style="color: red;">i</span> (en tant que gérant de recherche scientifique) à des
malades.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Pour la cultivation de chanvre en 2009 le requérant
fut déjà condamné par ce tribunal à une peine <span style="color: red;">avec</span>
sursis qui <span style="color: red;">a </span>fait l'objet d'une requête devant
la Cour (numero pas encore attribu<span style="color: red;">é</span> – pour les
preuves et griefs detaillés se rapportant à cette condamnation<span style="color: red;"> que</span> la Cour veuille bien se reférer à cette requête
envoyée le 10. Octobre 2012, ladite requête figure ci-dessous comme annexe
8).<span style="mso-spacerun: yes;"> </span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">En <span style="color: red;">bref</span> on p<span style="color: red;">eut</span> dire que tout le long des procès pour la
cultivation en 2009 nullement fut objectivement discuté et pris en compte
l'objection du requérant que du point de vu<span style="color: red;">e</span> du
progrès scientifique on ne puisse ignorer le profit individuel et social du
traitement de certaines maladies à l'aide <span style="color: red;">du</span>
chanvre (diabète, eczéma, maladie <span style="color: red;">de</span> Parkinson,
cancer etc).</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Persuadé qu'un tel refus catégorique se heurte à
l'idée de dignité de la vie et santé humaine le requérant avanca un argument
formel et très efficace:</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">L'inapplicabilité[1] de dispositions clés[2]de la loi
tchèqu<span style="color: red;">e</span> sur les stupéfiants d<span style="color: red;">û</span> à la non-notification[3] de cette loi selon la
directive 98/34/CE. De ce fait le requérant ne peut pas être considéré du point
de vu<span style="color: red;">e</span> du droit pénal comme personne <span style="color: red;">agissant</span> sans autori<span style="color: red;">satio</span>n
à mani<span style="color: red;">pul</span>er <span style="color: red;">les</span>
stupéfiant<span style="color: red;">s</span>[4] et doit être acquitté .</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">R<span style="color: red;">e</span>fusant de pos<span style="color: red;">er</span> une question préjudicielle à la CJCE<span style="color: red;">,</span> <span style="color: red;">l</span>es juridictions
tchèques se born<span style="color: red;">èrent</span> à <span style="color: red;">répondre</span>
que la loi sur les stupéfiants profite de l'exception[5] de l'obligation de
notification parce qu'elle se limite à la tranpositions de droit de l'UE
contraignantes et notam<span style="color: red;">m</span>ent de réglements.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Mais alors pourquoi est-ce-que la CJCE a priori
interdit la tran<span style="color: red;">s</span>position de réglements
communautaires[6]? Et pourq<span style="color: red;">uoi</span> est-ce-que les
juridictions sont elles restées muettes <span style="color: red;">devant</span>
les rev<span style="color: red;">e</span>ndications répétées du requérant à bien
vouloir prouv<span style="color: red;">er</span> leur affirmation en identifiant
la norme communautaire exigant tranposition par l'Etat membre[7]?</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Parce que l'affirmation des juridictions est purement
et simplement fausse ce qui ne peut plus être étouffé vu qu' entre<span style="color: red;">-</span>temps le Parl<span style="color: red;">e</span>ment et
le Gouvernement tchèque ont infirmé<span style="color: red;">s</span> par leur
comportement même l'affirmation des juridictions:</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">La Chambre des députés tchèque a adopté un amendement
de la loi sur les médicaments dont l'obje<span style="color: red;">ctif</span>
est la libéralisation du chanvre pour le traitement des malades[8]. Ce fait
infirme l'argumentation des juridictions que des normes communautaires
imposerai<span style="color: red;">en</span>t <span style="color: red;">l'</span>interdiction
de la cultivation du chanvre.<span style="mso-spacerun: yes;"> </span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Lors d<span style="color: red;">u</span> procès
legislatif de cet amendement l'Institut parlementaire (organe de recherche de
la Chambre des députés) a conseillé à ce que l'amendement de la loi soit
notifié selon la directive 98/34/ES en tant que norme non harmonisée – (voir
annexe 4 – analyse de l'Institut parlementaire).<span style="mso-spacerun: yes;"> </span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">De surcro<span style="color: red;">î</span>t le Minist<span style="color: red;">è</span>re de la Santé tchèque a procédé (pour la première
fois) à la notification de la loi sur les stupéfiants selon la directive
98/34/CE – cf. notification dans la base de données « TRIS » de la Commission
Européenne num<span style="color: red;">é</span>ro 2012/329/CZ[9].</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Est-ce un ha<span style="color: red;">s</span>ard que
dans ce contexte doit<span style="color: red;">-</span>intervenir la mesure
attaquée de privation de capacité juridique du requérant par le Tribunal
d'Olomouc – voir Annexe 1?</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Est-ce un ha<span style="color: red;">s</span>ard
qu'avant cela le Tribunal de Prostějov devant clôturer les affaires pénales
pendantes pour les récoltes jusqu'en 2012 accueille dans l'affaire de la
récolte 2010 la demande du parquet selon laquelle le requérant ne fut capable
de discerner le caractère délictuel de son comportement et refuse les plaintes
contre cette décisio<span style="color: red;">n</span> (voir annexe 5 – Requête
devant la Cour Constitutionnelle pour la culture 2010)?</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Est-ce un ha<span style="color: red;">s</span>ard que ce
même Tribunal de Prostějov r</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">é</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">ouvre à la demande du parquet la proc<span style="color: red;">é</span>dure déjà définitivement jugée pour la condamnation
du requérant pour la récolte de 2009 (faisant l'objet de la requête de la Cour
– voir Annexe 8) en constatant l'irresponsablilité pénale du requérant (ce qui
a incidemment pour effet d'arrêter le réexamen pour violation de la loi par le
Ministère de la Justice – voir annexe 6 – Déclaration du Ministère de la Justice
d'arrêter le réexamen) ?</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Est-ce un ha<span style="color: red;">s</span>ard que la
seule expertise psychiatrique utilisée par les tribunaux s'appui<span style="color: red;">e</span> exclusivement <span style="color: red;">sur </span>l'hospitalisation
psychiatrique très controversée[10]du requérant en l'an 2003 ? ce qui d'après
la Cour ne satisfait à l'exigence de specificité de la preuve que le requérant
ne soit (actuellement) pas en mesure de prendre soin de <span style="color: red;">lui</span>-même ou qu'il représente un danger (<span style="color: red;">actuel</span>)
pour autrui (jugement de la Cour affaire X et Y contre Croatie č. 5193/09). </span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Est-ce habituel que le seul expert psychiatrique
entendu par les tribunaux conclu</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">e</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"> que l'accusé ne puisse discerner le caractère
délictuel de son comportement s'il délibérement plante quatre printemps de
suite (2009 à 2012) du chanvre (ce qu'il notifie également aux organes
étatiques pour promouvoir ce sujet de société), <span style="color: red;">surveille</span>
pendant l'été la croissance du chanvre pour le récolter en automne et sur la
base d'exp<span style="color: red;">é</span>riences empirique<span style="color: red;">s</span> l'applique sous maintes formes (avec mais aussi sans
effet stupéfants) à des maladies spécifiques ce qui lui<span style="color: red;">,
soi dit </span><span style="mso-spacerun: yes;"> </span>en passant <span style="color: red;">a</span> apport<span style="color: red;">é</span> de main<span style="color: red;">ts</span> honneu<span style="color: red;">rs</span> et prix
tchèques et étrangers? <span style="color: red;">En vue de </span><span style="mso-spacerun: yes;"> </span>la protestation de l'expert psychiatrique
contre l'usage abusi<span style="color: red;">f</span> de son expertise par les
tribunaux (voir annexe 2) on peut arriver à la conclusion que le b<span style="color: red;">ut</span> initial de l'expertise était d'aider<span style="mso-spacerun: yes;"> </span>le requérant contre les accusations vu
l'intensité criminelle immense de la fourniture de chanvre aux malades.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Est-ce un ha<span style="color: red;">s</span>ard que le
Tribunal de Prostějov sans fondement suffissament motivé<span style="mso-spacerun: yes;"> </span>livre l'expertise psychiatrique au Tribunal
de Prague 3 statuant sur une cause civile du req</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">u</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">érant et que ce Tribunal
de Prague 3 (voir Annexe7) s'adresse sans aucun fondement motivé au Tribunal
d'Olomouc en tant que tribunal du lieu de résidence officiel du requérant à le
faire déclarer inca<span style="color: red;">pable</span> non seulement
pénalement mais civiquement ? Est-ce un ha<span style="color: red;">s</span>ard
que le Tribunal d'Olomouc ini<span style="color: red;">t</span>ie la procéd<span style="color: red;">ure</span> de privation de capacité jurid<span style="color: red;">i</span>que sans prendre de vérification supplémentaire,
c.a.d. en se bornant aux faits et à l'expertise fourni<span style="color: red;">s</span>
par le Tribunal de Prostějov.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Bien que la Cour soit toute libre <span style="color: red;">de conclure ce qui lui convient</span>, le requérant soutient
qu'il soit certain ou au moin<span style="color: red;">s</span> que le contexte
des faits gén<span style="color: red;">è</span>re un doute sérieux et
insurmontable que la mesure de privation de capacité juridique par le Tribunal
d'Olomouc (faisant l'objet du présent recour<span style="color: red;">s</span> et
pouvant être prononcé<span style="color: red;">e</span> dès l'audience du 10.
Janvier 2013) prend source dans une entente proc<span style="color: red;">é</span>dural<span style="color: red;">e</span> au moins implicite entre les tribunaux de Prague,
d'Olomouc et de Prostějov – ce dernier ne pouvant pas prononc</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">er</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"> le requérant coupable vu
l'inapplicabilité de la loi tchèques sur les stupéfiants<span style="color: red;">,</span> essay<span style="color: red;">ant</span> de se dénier de sa
fonction et de ses responsabilit<span style="color: red;">és</span> de cette
manière en niant tout principe d´état de droit.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Bien qu'on ne puisse exclure que cette d<span style="color: red;">é</span>marche des juridictions soit faite dans une intention
« amicale et de compromis» puisque le requérant risque après la condamnation à
une peine à sursis pour 2009 une peine de prison pour tout autre condamnation,
le requérant ne dispose d'aucune garantie que ceci soit le juste et seul motif
et que les juridictions se borneront « seulement » en le privant de la capacité
juridique de le rendre « i<span style="color: red;">m</span>puni<span style="color: red;">s</span>sable » sans prend<span style="color: red;">re</span>
d'autre mesur<span style="color: red;">e</span> (tutelle judiciaire, <span style="color: red;">h</span>ospitalisation psychiatrique arbitraire) ayant le
caractère de peine ou <span style="color: red;">de </span>répression.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">En revanche il est dommage que les juridictions n'<span style="color: red;">aien</span>t pas perçu les allusions « amicales » du
requérant qui avait dans la proc<span style="color: red;">é</span>dure concernant
2009 soutenu que seul l'usage de stupéfiants pour b<span style="color: red;">u</span>ts
m<span style="color: red;">é</span>dicaux tombe sous la protection du d<span style="color: red;">r</span>oit de l´UE (CJCE C-137/09 Josemans, para. 36 a 38)
et de ce fait il ne fallait pas craindre de préc<span style="color: red;">é</span>dent
appliquable à toute accusation concernant des stupéfi<span style="color: red;">an</span>ts.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Le requérant conclu qu'une fois la mesure de privation
de capacité juridique du requérant pris, celle-ci constituera en elle-même une
violation grave et injustifiée de l'Art. 8 de la Convention dont la conséquence
recherchée est de rendre impossible[11] l'exercice de l'Art. 6 phrase première
de la Convention garantissant le droit de toute personne à ce que le bien-fondé
de toute accusation pénale contre elle soit décid<span style="color: red;">é</span>
par le tribunal non seulement comp<span style="color: red;">é</span>tent, c.a.d.
designé par la loi, mais aussi de manière impartial<span style="color: red;">e</span>,
c.a.d. respectant l'état de droit et ne se d<span style="color: red;">é</span>niant
pas de ses fonctions et responsabilit<span style="color: red;">és</span> vu qu'il
s'agit d'un sujet de société.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Fa<span style="color: red;">it</span> à Olomouc le 8.
Janvier 2013 </span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"><span style="mso-spacerun: yes;"> </span>Dušan Dvořák, v.r.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"><span style="mso-spacerun: yes;"> </span>Annexes</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<br /></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"><span style="mso-spacerun: yes;"> </span>Annexe 1<span style="mso-spacerun: yes;"> </span>- l'ord</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">o</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">nnance de l'audience du tribunal d'Olomouc p</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">a</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">ru</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">e</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"> le 10. janvier 2013
statuant sur la capacité jurid</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">ique</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"> du requérant</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">.</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Annexe 2 – protestation<span style="mso-spacerun: yes;"> </span>de l'expert psychiatrique</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">.</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Annexe 3 – récapitulation des prostestations</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">.</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Annexe 4 – Anal</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">yse</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"> de l'Institut
parlementaire en ce qui concerne la notification de l'amendement de la loi sur
les médicaments selon la directive 98/34/CE</span><span lang="FR" style="color: red; font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: FR; mso-bidi-font-family: Calibri;">.</span><span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;"></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Anexe 5 - Requête du <span style="color: red;">24</span>
décembre 2012 devant la Cour Constitutionnelle pour la culture de 2010</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Annexe 6 – Déclaration du Ministère de la Justice
d'arrêter le réexamen d<span style="color: red;">ue</span> au renouvellement du
procés<span style="color: red;">.</span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Anexe 7 – Déclarations du Tribunal de Pratur 3
concernant la privation de la capacité juridique du requérant<span style="color: red;">.</span> </span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">Annexe 8 – Requêt du <span style="color: red;">10</span>
Octobre 2012 faite devant la Cour Européenne des droits de l'homme pour la
culture de 2009.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[1]Jurisprudence constante depui<span style="color: red;">s</span> l'arrêt de la CJCE affaire C-194/94 CIA, para. 54.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[2]Dispositions de la loi tchèqu<span style="color: red;">e</span> sur les stupéfiants concernant l'autorisation à
manier <span style="color: red;">les</span> stupéfiant<span style="color: red;">s</span>
et interdisant la cultivation de chanvre.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[3]La notification aurait d<span style="color: red;">û</span>
intervenir en 2009 lors de la modification du régime d'autorisation par
l'amendement fait<span style="color: red;">e</span> par la loi n. 141/2009 Coll.,
du 28. Avril 2009 amendant la loi n. 167/1998 Coll., sur les stupéfiants<span style="color: red;">.</span></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[4]Voir a deductio arrêt de la CJCE affaire C-20/05
Procédure pénale contre Schwibbert.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[5]Art. 10 par. 1 de la directive 98/34/CE.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[6]Arrêt de la CJCE affaire 34/73 Variola.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[7]Arrêt de la CJCE affaire C-289/94 ES contre Italy,
para 36, 43 a 44.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[8]Document de la Chambre des députés 590/0 site <a href="https://www.blogger.com/www.psp.cz"><span style="color: blue;">www.psp.cz</span></a>, rubrique «
Jednání a dokumenty » ; rubrique « navržené »; <a href="http://www.psp.cz/sqw/text/tiskt.sqw?O=6&CT=590&CT1=0"><span style="color: blue;">http://www.psp.cz/sqw/text/tiskt.sqw?O=6&CT=590&CT1=0</span></a></span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[9]Site ec.europa.eu/enterprise/tris, rubrique „search
by number…“</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[10]Cette h<span style="color: red;">osp</span>italisation
fut la conséquence de la non soumission du requérant en tant que
psychothérapeute aux opi<span style="color: red;">n</span>ions profesionnelles de
ses collègues psychothérapeutes. Après avoir été enfermé pendant cette
hôpitalisation dans une cage le requérant en collaboration avec l'ombudsman ont
contribué en 2005 à l'abolition législatif de ce traitement inhumain <span style="color: red;">et </span>dégradant.</span></div>
<div class="MsoNormal" style="mso-layout-grid-align: none; mso-pagination: none; text-autospace: none;">
<span lang="fr" style="font-family: "Bookman Old Style","serif"; font-size: 12.0pt; line-height: 115%; mso-ansi-language: #000C; mso-bidi-font-family: Calibri;">[11]Il est <span style="color: red;">é</span>vident que
même si le requérant obt<span style="color: red;">enait</span> dans le futu<span style="color: red;">r</span> la levée de la privation de capacité juridique (ce
qui est incertain), le requérant ne dispose d'aucun moyen qui forçerait les
juridictions à r<span style="color: red;">é</span>initier les proc<span style="color: red;">é</span>dures pénales pour cultivation <span style="color: red;">de</span> chanvre lesquelles seront entretemps arrêtées d<span style="color: red;">û</span> a la privation de s<span style="color: red;">a</span>
capacité juridique.</span></div>
</div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-4288123488878715524.post-18102801422033492002015-05-30T06:16:00.001-07:002015-05-30T09:38:38.800-07:00Reference number CHAP (2014) 3930<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>Cannabis
is The Cure,z.s</b></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">,
<a href="http://cannainsider.eu/">http://cannainsider.eu/</a> </span></span>
</div>
<div style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">IN:
266 70 232, Tylova 963/2, CZ 779 00 Olomouc</span></span></div>
<div style="margin-bottom: 0cm;">
<br />
</div>
<div align="RIGHT" style="margin-bottom: 0cm;">
<br />
</div>
<div align="RIGHT" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>European
Commission </b></span></span>
</div>
<div align="RIGHT" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>CHAP(2014)
3930 </b></span></span></div>
<div align="RIGHT" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm; text-indent: 1.25cm;">
<br />
</div>
<div lang="en-GB" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>Preliminary
questions to European Court of Justice </b></span></span>
</div>
<div style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm;">
<a href="https://www.blogger.com/null" name="result_box"></a>
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><i><u><b>These
questions with evidence of repeated violations of EU law prohibits
the Czech Republic to discuss the EU Court of Justice </b></u></i></span></span>
</div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm; text-indent: 0.61cm;">
<br />
</div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>Question
number three is updated. </b></span></span></span>
</div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm; text-indent: 0.61cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-size: medium;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB">1)</span></span><span style="font-variant: normal;">
</span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB">Does
article 267 par. 3 of the </span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><i>Treaty
on the Functioning of the European Union</i></span></span> <span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB">have
to be interpreted as preventing the Supreme Court from taking action,
which the Supreme Court cites as reason to refuse to grant permission
to pose preliminary questions to the European Court of Justice
regarding the unenforceability of legal provisions of the </span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><i>Act
167/1998 Coll. on Addictive Substances</i></span></span> <span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB">(</span></span><span style="font-family: Microsoft Sans Serif, sans-serif;">Zákon
o návykových látkách</span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB">,
henceforth Addictive Substances Act), based the on the finding of the
Czech Supreme Court </span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><i>(ref.
No. 8 Tdo 1231/2011, note. also claims of the Czech Constitutional
Court ref. No. II. ÚS 664/12, IV. ÚS 4859/12, II. ÚS 289/14,
European Court of Human Rights ref. No. 66981/12, 79490/13, 20049/14,
47921 and European Commission CHAP (2012) 00282 </i></span></span><span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><i><b>and
</b></i></span></span></span><span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en"><i><b>possibly
also</b></i></span></span></span><span style="color: #c5000b;"> </span><span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><i><b>(2014)
03930</b></i></span></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><i>)
</i></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB">that
the Addictive Substances Act transposes a legal provision of the
European Community, specifically an EC directive, </span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en-GB"><u>which
however must not be transposed.</u></span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">2)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Given that following Act 362/2004 Coll
(CZ), which amends the Addictive Substances Act, the legal regime of
growing hemp for research (experimental) and industrial purposes has
shifted from regime under which growing hemp was not allowed without
prior notice to authorities to regime under which growing hemp
without prior notice to authorities is allowed up to a growing area
of 100</span><sup><span lang="en-GB">m2</span></sup> <span lang="en-GB">per
person, </span><span lang="en-GB"><u>does § 29 of the Addictive
Substances Act represent a technical regulation</u></span> <span lang="en-GB">in
the sense of art. 1 par. 11 of the directive 98/34/EC and is it thus,
considering that this clause has not been notified to the European
Commission in accordance with art. 8 and 9 of the directive 98/34/EC,
</span><span lang="en-GB"><u>unenforceable</u></span> <span lang="en-GB">in
terms of the European Court of Justice ruling concerning C-194/94 CIA
</span><span lang="en-GB"><i>Security International</i></span><span lang="en-GB">,
point 55?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">3)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does the European Commission regulation
(EC) No. 1122/2009 for determining of narcotic and non-narcotic hemp
varieties following the “</span><span lang="en-GB"><i>Community
method for quantitative determination of Δ 9-tetrahydrocannabinol
content in hemp varieties”</i></span> <span lang="en-GB">(Annex I
of the regulation from November 30, 2009), have to be interpreted as
preventing other methods for determining Δ9-tetrahydrocannabinol
content in hemp varieties and their narcotic effects, than the method
listed in the regulation from being enacted?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">4)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does art. 5 par. 5 of the Addictive
Substances Act represent a regulation in the sense of art. 1 par. 11
of the Directive </span><span lang="en-GB"><i>98/34/EC</i></span>
<span lang="en-GB">since its amendment by </span><span lang="en-GB"><i>Act
(CZ) 50/2013 Coll.</i></span> <span lang="en-GB">establishes a new
THC content threshold for research (experimental) and industrial
purposes, up to 0, 3 % THC content, and is it thus, since the clause
has not been notified to the European Commission in accordance with
art. 8 and 9 of the directive 98/34/EC, </span><span lang="en-GB"><u>unenforceable</u></span>
<span lang="en-GB">in terms of the European Court of Justice ruling
concerning C-194/94 CIA </span><span lang="en-GB"><i>Security
International</i></span><span lang="en-GB">, point 55?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">5)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does art. 5 par. 5 of the Addictive
Substances Act represent a regulation in the sense of art. 1 par. 11
of the Directive </span><span lang="en-GB"><i>98/34/EC</i></span>
<span lang="en-GB">since it changes the legal regime of manipulation
with addictive substances from regime under which licences for
manipulation with addictive substances could not applied for to a
regime under which licences for manipulation can be applied for in
accordance with Act No. 141/2009 Coll. (CZ), which amended the
Addictive Substances Act and is it thus, considering that this clause
has not been notified to the European Commission in accordance with
art. 8 and 9 of the directive 98/34/EC, </span><span lang="en-GB"><u>unenforceable</u></span>
<span lang="en-GB">in terms of the European Court of Justice ruling
concerning C-194/94 CIA </span><span lang="en-GB"><i>Security
International</i></span><span lang="en-GB">, point 55?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">6)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does art. 9 of the directive 98/34/EC have
to be interpreted as preventing the passing of a regulation without
delay for urgent reasons according to art. 7 of the directive for
national regularization such as </span><span lang="en-GB"><i>Decree
No. 221/2013 Coll. which states the conditions for prescription,
preparation, dispensing and use of individually prepared
pharmaceutical agents</i></span> <span lang="en-GB">(CZ), which
states the requirements for the properties of medicinal hemp?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">7)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does art. 24a of the Addictive Substances
Act represent a regulation in the sense of art. 1 par. 11 of the
Directive </span><span lang="en-GB"><i>98/34/EC</i></span> <span lang="en-GB">as
it establishes the requirement of having a licence for growing hemp
and is it thus, since the clause has not been notified to the
European Commission in accordance with art. 8 and 9 of the directive
98/34/EC, </span><span lang="en-GB"><u>unenforceable</u></span> <span lang="en-GB">in
terms of the European Court of Justice ruling concerning C-194/94 CIA
</span><span lang="en-GB"><i>Security International</i></span><span lang="en-GB">,
point 55?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">8)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does art. 24b of the Addictive Substances
Act represent a regulation in the sense of art. 1 par. 11 of the
Directive </span><span lang="en-GB"><i>98/34/EC</i></span> <span lang="en-GB">as
it requires that all medicinal hemp be turned in to the State
Institute for Drug Control and is it thus, since the clause has not
been notified to the European Commission in accordance with art. 8
and 9 of the directive 98/34/EC, </span><span lang="en-GB"><u>unenforceable</u></span>
<span lang="en-GB">in terms of the European Court of Justice ruling
concerning C-194/94 CIA </span><span lang="en-GB"><i>Security
International</i></span><span lang="en-GB">, point 55?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">9)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does article No. 34 of the </span><span lang="en-GB"><i>Treaty
on the Functioning of the European Union</i></span> <span lang="en-GB">have
to be interpreted as estopping national regulation such as Act No.
378/2007 Coll. on pharmaceuticals (CZ), Addictive Substances Act and
decree No. 221/2013 Coll. (CZ), since these regulations set the
requirements for the properties of medicinal hemp which de facto has
to be imported from the Netherlands where it is grown for use as a
narcotic and which is demonstrably less suitable for medicinal
purposes than other (nationally produced or imported) strains of
hemp, including non-narcotic hemp strains and non-narcotic methods of
application of narcotic hemp, which are not allowed for medicinal
use?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">10)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Considering the findings of the European
Court of Justice in C-137/09 Josemans, which explicitly state the
admissibility of using narcotic substances such as hemp for medical
and research purposes, does article No. 34 of the </span><span lang="en-GB"><i>Treaty
on the Functioning of the European Union</i></span> <span lang="en-GB">have
to be interpreted as estopping national regulation which only allows
the use of medically unsuitable hemp (imported from the Netherlands),
primarily intended for intoxication and under legal sanctions
prohibits all growing, research and use of other (nationally produced
or imported) hemp strains, which would be more suitable for medicinal
purposes?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">11)</span><span style="font-variant: normal;">
</span><span lang="en-GB">Does art. 15 e) of the Addictive Substances
Act represent a regulation in the sense of art. 1 par. 11 of the
Directive </span><span lang="en-GB"><i>98/34/EC</i></span> <span lang="en-GB">as
it changes the legal regime of separation substances from hemp for
research and medical purposes from regime where this was not allowed
to a regime when it may be allowed based on Act No. 50/2013 Coll.
(CZ) which amended the Addictive Substances Act and is it thus, since
the clause has not been notified to the European Commission in
accordance with art. 8 and 9 of the directive 98/34/EC, </span><span lang="en-GB"><u>unenforceable</u></span>
<span lang="en-GB">in terms of the European Court of Justice ruling
concerning C-194/94 CIA </span><span lang="en-GB"><i>Security
International</i></span><span lang="en-GB">, point 55?</span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en-GB">Olomouc,
30/05/201</span><span lang="en-GB">5</span></span></span></div>
<div align="JUSTIFY" lang="en" style="line-height: 107%; margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" lang="en" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Dušan
Dvořák, MMCA</span></span></div>
<div align="JUSTIFY" lang="en" style="line-height: 107%; margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Chairman
of the Board </span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<a href="http://dusan-dvorak.eu/"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">http://dusan-dvorak.eu/</span></span></a></div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<br /><br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en">A</span></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en">nnex
</span></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en"><a href="http://eu-commission.blogspot.cz/">http://eu-commission.blogspot.cz/</a>
</span></span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en">More
information about the proceedings at the European Commission found in
the Czech language on</span></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">
<a href="http://evropskakomise.blogspot.cz/">http://evropskakomise.blogspot.cz/</a>
</span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en">More
information about the proceedings before the European Court of Human
Rights, which has since 2012 filed seven complaints against Czech
Republic finds here </span></span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><a href="http://echr-coe-int.blogspot.cz/">http://echr-coe-int.blogspot.cz/</a>
</span></span><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en">European
Court of Human Rights as well as the Czech Constitutional Court
always dismissed the complaint on the Czech Republic and a violation
of the Convention on Human Rights discussed without any
justification. </span></span></span><span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en"><b>Doctors
and forensic experts yet demonstrated that the Czech Republic's
conduct caused serious bodily injury, including injury resulting in
death.</b></span></span></span></span></div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><br />European
Commission complaint in 2013 refused to pass EU Court of Justice,
despite evidence of a breach of EU law are unquestionable and brutal.</span></span></div>
<div align="JUSTIFY" lang="en" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-size: medium;"><b><span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span lang="en">As
decided by the European Commission in 2015, when evidence of gross
violations of EU law added?</span></span></span> </b></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><a href="http://cannabis-europe.eu/">http://cannabis-europe.eu/</a>
</span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><span lang="en">The
damage caused to the research, investors and participants of the
research is at least 33 million euros. Damane</span> to thwart
legislative arrangements World cannabis growing is € 1,000,000 <span lang="en">It
was also given the European Commission a request to halt the tender
to supply cannabis to pharmacies and supported by the necessary
evidence of violation of the Czech and EU law.</span> </span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b><span lang="en">European
Commission translators in Czech</span> </b></span></span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><a href="http://ec.europa.eu/growth/tools-databases/tris/en/search/?trisaction=search.detail&year=2013&num=288">http://ec.europa.eu/growth/tools-databases/tris/en/search/?trisaction=search.detail&year=2013&num=288</a>
</span></span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>12.
Grounds for the Emergency (for smoking)</b></span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><br />Grounds
for the emergency: </span></span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><br />As
stated under point 8 of the notification form, amendments to the
Drugs Act and the Act on Addictive Substances were adopted on the
initiative of MPs. The amendments to the above acts allow for the use
of cannabis in magistral medicinal products for medical use. </span></span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><br />The
reason for the emergency is that the amendments need to be urgently
“brought to life”, including by means of the present draft
Decree, so that certified pharmacies may prepare cannabis-containing
medicinal products and significantly reduce illegal sale of these
products. </span></span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><br />Any
further delay threatens the health of patients who buy illegally
prepared products of unspecified and, above all, unknown cannabinoid
content. This situation promotes illegal cannabis cultivation and
trafficking, which is linked with other criminal activities
associated with organised crime. </span></span></span>
</div>
<h2 align="JUSTIFY" class="western">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Důležité
pro řízení - důkazní řetězec justičně exekutivní korupce</span></span></h2>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">ZDROJ:
Databáze TRIS Evropské komise </span></span>
</div>
<div align="JUSTIFY" style="margin-bottom: 0.5cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><a href="http://ec.europa.eu/growth/tools-databases/tris/cs/search/?trisaction=search.detail&year=2013&num=288" target="_blank">http://ec.europa.eu/growth/tools-databases/tris/cs/search/?trisaction=search.detail&year=2013&num=288</a></span></span></div>
<h2 align="JUSTIFY" class="western">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Dodnes
nesmí lidé získat kvalitní a cenově dostupnou medicínskou mast,
čípky, spray, kapky, tinktury atd., musí jen kouřit, viz citace
§§ 24 a) a 24b) zákona o návykových látkách!</span></span></h2>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Ze
zprávy České republiky Evropské komisi k urychlené notifikaci
vyhlášky MZ ČR č. 221/2013 Sb. <b>dle Směrnice 98/34/ES </b>s
nezákonnou monopolizací 4 holandských genetik konopí firmy
Bedrocan <span style="color: #c5000b;"><span style="text-decoration: none;"><b>v
rámci nouzového režimu dne 30.05.2013</b></span></span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>CITACE
<u>zdůvodnění požití naléhavé procedury dle nouzového režimu
vyhrazeného katastrofám</u> jako byla v ČR např. metanolová
kauza:</b></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<span style="color: #c5000b;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;"><b>Každý
další odklad ohrožuje zdraví pacientů, kteří si pořizují
nelegálně připravované přípravky s neuvedeným a hlavně
neznámým množstvím obsahu konopí. Tato situace podporuje
nelegální pěstování a obchod s konopím, který se váže na
další kriminální činnosti spojené s organizovaným zločinem.</b></span></span></span></div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 0.5cm; margin-bottom: 0cm;">
<span style="color: black;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Have
a nice day, good health and well-being of permanent </span></span></span>
</div>
<div align="JUSTIFY" style="line-height: 0.5cm; margin-bottom: 0cm;">
<br />
</div>
<div align="JUSTIFY" style="line-height: 0.5cm; margin-bottom: 0cm;">
<span style="color: black;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Dušan
Dvořák, MMCA </span></span></span>
</div>
<div align="JUSTIFY" style="line-height: 0.5cm; margin-bottom: 0cm;">
<span style="color: black;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">Cannabis
not only cures cancer </span></span></span>
</div>
<div align="JUSTIFY" style="line-height: 0.5cm; margin-bottom: 0cm;">
<a href="http://www.cannainsider.eu/" target="_blank"><span style="color: black;"><span style="font-family: Microsoft Sans Serif, sans-serif;"><span style="font-size: medium;">http://www.CannaInsider.eu/</span></span></span></a></div>
<div style="margin-bottom: 0cm;">
<br />
</div>
</div>
Unknownnoreply@blogger.com